James T. Rosenbaum, MD, MACR, is the Richard Chenoweth Chair Emeritus, Legacy Devers Eye Institute, Legacy Health Systems, Portland, Ore.; and senior vice president for research, Corvus Pharmaceuticals, Burlingame, Calif.
Dr. Rosenbaum was an academic rheumatologist for 41 years, including his first faculty position at the University of California, San Francisco School of Medicine, two years directing the Kuzell Institute at California Pacific Medical Center, San Francisco, and nearly 37 years at Oregon Health & Science University, Portland, where he was rheumatology division chief for 21 years and held the Edward E Rosenbaum Professorship, named in honor of his father. From 2012–19, he was concurrently Richard Chenoweth Chair of Ophthalmology at Legacy Devers Eye Institute. In July 2022, he became senior vice president for research at Corvus Pharmaceuticals.
Dr. Rosenbaum is part of a renowned, multi-generation, eight-physician family that includes his late father, his wife, two brothers, his sister-in-law and two daughters.
“I am very grateful to my family, my colleagues, my teachers, my patients, my nominators, the selection committee, and the ACR and Rheumatology Research Foundation. I also recognize that many others are deserving of this honor,” says
Dr. Rosenbaum.
Distinguished Clinician Scholar Award
The Distinguished Clinician Scholar Award, awarded to a rheumatologist who has made outstanding contributions in clinical medicine, clinical scholarship or education, was presented this year to Michael D. Lockshin, MD, MACR, professor of medicine and obstetrics-gynecology at Weill Cornell Medicine, New York City, and the founding director of the Barbara Volcker Center for Women and Rheumatic Disease at the Hospital for Special Surgery, New York City. The Center focuses on issues special to women with rheumatic disease, antiphospholipid syndrome, and undifferentiated and overlap rheumatic disease.
